Lupus & Connective Tissue Diseases
Conference Coverage
Rituximab benefits seen in neuropsychiatric lupus
Findings from the largest prospective study of rituximab for NPSLE to date show signs of rituximab’s efficacy in reducing neuropsychiatric disease...
Feature
Patient benefits justify price of new lupus nephritis drugs
Prices of two new drugs approved by the FDA for lupus nephritis are in reasonable alignment with their estimated benefits for patients with the...
Feature
Boosting the presence of darker skin in rheumatology education
Doctors are beginning to address educational gaps in rheumatologists’ exposure to rheumatic and musculoskeletal diseases in people with darker...
From the Journals
Most patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccination
A preprint publication of a study of 133 people with chronic inflammatory disease and 53 controls shows that those with CID mount immune responses...
Conference Coverage
Black patients with cutaneous sarcoidosis may have more systemic and CV disease
Black patients were significantly more likely to have two or more organs involved and have higher rates of cardiac involvement.
From the Journals
Renal, cardiovascular damage may develop in mild SLE despite treatment
An increase in disease activity in systemic lupus erythematosus is associated with significant increases in the risk of renal and cardiovascular...
From the Journals
Rheumatology clinics find success with smoking cessation referral program
Clinics that adopted a protocolized, EHR-based approach to checking for readiness to quit saw a 26-fold increase in quit-line referrals.
Feature
VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves
From the Journals
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...
From the Journals
COVID-19’s impact on lupus inpatients examined in study
Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a...
Conference Coverage
Checkpoint inhibitor–induced rheumatic complications often arise late
Rheumatologic adverse events associated with immune checkpoint inhibitors can happen later in the course of treatment but also can continue after...